Anti-Prostate Specific Antigen antibody (ab53774)
Key features and details
- Rabbit polyclonal to Prostate Specific Antigen
- Suitable for: WB, IHC-P
- Reacts with: Mouse, Human
- Isotype: IgG
Overview
-
Product name
Anti-Prostate Specific Antigen antibody
See all Prostate Specific Antigen primary antibodies -
Description
Rabbit polyclonal to Prostate Specific Antigen -
Host species
Rabbit -
Specificity
This antibody detects endogenous levels of total Prostate Specific Antigen protein. -
Tested Applications & Species
Application Species IHC-P HumanWB Mouse -
Immunogen
Synthetic peptide derived from human Prostate Specific Antigen
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles. -
Storage buffer
pH: 7.40
Preservative: 0.02% Sodium azide
Constituents: 50% Glycerol, 0.87% Sodium chloride, PBS -
Concentration information loading...
-
Purity
Immunogen affinity purified -
Clonality
Polyclonal -
Isotype
IgG -
Research areas
Associated products
-
Compatible Secondaries
-
Isotype control
-
Recombinant Protein
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab53774 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Tested applications are guaranteed to work and covered by our Abpromise guarantee.
Predicted to work for this combination of applications and species but not guaranteed.
Does not work for this combination of applications and species.
Application | Species |
---|---|
IHC-P |
Human
|
WB |
Mouse
|
Application | Abreviews | Notes |
---|---|---|
WB | (1) |
1/500 - 1/1000. Detects a band of approximately 34 kDa (predicted molecular weight: 29 kDa).
|
IHC-P |
Use at an assay dependent concentration.
|
Notes |
---|
WB
1/500 - 1/1000. Detects a band of approximately 34 kDa (predicted molecular weight: 29 kDa). |
IHC-P
Use at an assay dependent concentration. |
Target
-
Function
Hydrolyzes semenogelin-1 thus leading to the liquefaction of the seminal coagulum. -
Sequence similarities
Belongs to the peptidase S1 family. Kallikrein subfamily.
Contains 1 peptidase S1 domain. -
Cellular localization
Secreted. - Information by UniProt
-
Database links
- Entrez Gene: 354 Human
- Entrez Gene: 16621 Mouse
- Omim: 176820 Human
- SwissProt: P07288 Human
- SwissProt: P00756 Mouse
- Unigene: 171995 Human
- Unigene: 439740 Mouse
-
Alternative names
- antigen, prostate-specific antibody
- APS antibody
- Gamma seminoprotein antibody
see all
Images
-
All lanes : Anti-Prostate Specific Antigen antibody (ab53774) at 1/500 dilution
Lane 1 : Extracts from mouse heart
Lane 2 : Extracts from mouse heart, plus immunising peptide
Predicted band size: 29 kDa
Observed band size: 34 kDa why is the actual band size different from the predicted? -
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Prostate Specific Antigen antibody (ab53774)Ab53774 staining human normal prostate tissue. Staining is localised to cytoplasm and extracellular spaces.
Left panel: with primary antibody at 1 ug/ml. Right panel: isotype control.
Sections were stained using an automated system (DAKO Autostainer Plus ), at room temperature: sections were rehydrated and antigen retrieved with the Dako 3 in 1 AR buffer EDTA pH 9.0 in a DAKO PT Link. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 mins. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 min and detected with Dako envision flex amplification kit for 30 minutes. Colorimetric detection was completed with Diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that for manual staining we recommend to optimize the primary antibody concentration and incubation time (overnight incubation), and amplification may be requir
Protocols
Datasheets and documents
References (9)
ab53774 has been referenced in 9 publications.
- Coleman DJ et al. Maintenance of MYC expression promotes de novo resistance to BET bromodomain inhibition in castration-resistant prostate cancer. Sci Rep 9:3823 (2019). PubMed: 30846826
- Hua Y et al. Dual androgen receptor (AR) and STAT3 inhibition by a compound targeting the AR amino-terminal domain. Pharmacol Res Perspect 6:e00437 (2018). PubMed: 30410767
- Chen Q et al. Oxibendazole inhibits prostate cancer cell growth. Oncol Lett 15:2218-2226 (2018). PubMed: 29434928
- Richter H et al. Comparison of hock- and footpad-injection as a prostate adenocarcinoma model in rats. BMC Vet Res 14:327 (2018). PubMed: 30400793
- Olsen JR et al. Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes. BMC Cancer 16:377 (2016). WB ; Human . PubMed: 27378372
- Coleman DJ et al. Cellular androgen content influences enzalutamide agonism of F877L mutant androgen receptor. Oncotarget 7:40690-40703 (2016). PubMed: 27276681
- Volpetti F et al. A microfluidic platform for high-throughput multiplexed protein quantitation. PLoS One 10:e0117744 (2015). PubMed: 25680117
- Rodríguez-Lorenzo L et al. Plasmonic nanosensors with inverse sensitivity by means of enzyme-guided crystal growth. Nat Mater 11:604-7 (2012). Human . PubMed: 22635043
- Kottke T et al. Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors. Nat Med 17:854-9 (2011). PubMed: 21685898